中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2009年
9期
822-826
,共5页
段志良%张丽芳%张琴%李文姝%朱珊丽%陈俊%夏克栋%文金生
段誌良%張麗芳%張琴%李文姝%硃珊麗%陳俊%夏剋棟%文金生
단지량%장려방%장금%리문주%주산려%진준%하극동%문금생
细胞毒性T细胞%HLA-A2%免疫原性
細胞毒性T細胞%HLA-A2%免疫原性
세포독성T세포%HLA-A2%면역원성
Cytotoxic T lymphocytes%HLA-A2%Immunogenecity
目的 研究前期鉴定的5条丙型肝炎病毒(HCV)特异性细胞毒性T细胞(CTL)表位的HLA-A2限制性及其免疫学效应.方法 基于T2胞株,采用MHC-肽复合物稳定性试验研究前期鉴定的HCV特异性CTL表位与HLA-A2分子的亲和力;采用细胞内细胞因子染色(intracellular cy-tokine staining,ICS)和ELISPOT研究七述HLA-A2限制性CTL表位体外刺激HLA-A2刚性外周血单个核细胞(PBMC)产生肽特异性CTL的效应;采用CTL杀伤试验研究上述肽特异性CTL杀伤靶细胞(负载相同肽的T2细胞)的效应.结果 前期研究鉴定的5条CTL表位肽中,NS4b_78(SMMAF-SAAL)和NS5a_367(TVSSALAEL)与HLA-A2分子有高亲和力(FI1);ELISPOT结果显示NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)可诱导高水平的分泌IFN-γ的效应细胞[分别为(60±6)SFC/10~4PBMC vs(4±1)SFC/10~4PBMC,P<0.001;(10±3)SFC/10~4PBMC vs(2±1)SFC/10~4PBMC,P<0.001];ICS结果证实这两条肽刺激HLA-A2阳性PBMC后,在CD8~+T细胞中产生了高百分比的CD8~+IFN-γ~+T[分别为(2.33±0.22)%vs(0.05±0.01)%,P<0.001;(0.36±0.06)%vs(0.03±0.01)%,P<0.001];并且,肽特异性CTL可特异性杀伤负载相同肽的T2细胞.结论 NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)受HIA-A2限制,并具有较好的免疫原性.
目的 研究前期鑒定的5條丙型肝炎病毒(HCV)特異性細胞毒性T細胞(CTL)錶位的HLA-A2限製性及其免疫學效應.方法 基于T2胞株,採用MHC-肽複閤物穩定性試驗研究前期鑒定的HCV特異性CTL錶位與HLA-A2分子的親和力;採用細胞內細胞因子染色(intracellular cy-tokine staining,ICS)和ELISPOT研究七述HLA-A2限製性CTL錶位體外刺激HLA-A2剛性外週血單箇覈細胞(PBMC)產生肽特異性CTL的效應;採用CTL殺傷試驗研究上述肽特異性CTL殺傷靶細胞(負載相同肽的T2細胞)的效應.結果 前期研究鑒定的5條CTL錶位肽中,NS4b_78(SMMAF-SAAL)和NS5a_367(TVSSALAEL)與HLA-A2分子有高親和力(FI1);ELISPOT結果顯示NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)可誘導高水平的分泌IFN-γ的效應細胞[分彆為(60±6)SFC/10~4PBMC vs(4±1)SFC/10~4PBMC,P<0.001;(10±3)SFC/10~4PBMC vs(2±1)SFC/10~4PBMC,P<0.001];ICS結果證實這兩條肽刺激HLA-A2暘性PBMC後,在CD8~+T細胞中產生瞭高百分比的CD8~+IFN-γ~+T[分彆為(2.33±0.22)%vs(0.05±0.01)%,P<0.001;(0.36±0.06)%vs(0.03±0.01)%,P<0.001];併且,肽特異性CTL可特異性殺傷負載相同肽的T2細胞.結論 NS4b_78(SMMAFSAAL)和NS5a_367(TVSSALAEL)受HIA-A2限製,併具有較好的免疫原性.
목적 연구전기감정적5조병형간염병독(HCV)특이성세포독성T세포(CTL)표위적HLA-A2한제성급기면역학효응.방법 기우T2포주,채용MHC-태복합물은정성시험연구전기감정적HCV특이성CTL표위여HLA-A2분자적친화력;채용세포내세포인자염색(intracellular cy-tokine staining,ICS)화ELISPOT연구칠술HLA-A2한제성CTL표위체외자격HLA-A2강성외주혈단개핵세포(PBMC)산생태특이성CTL적효응;채용CTL살상시험연구상술태특이성CTL살상파세포(부재상동태적T2세포)적효응.결과 전기연구감정적5조CTL표위태중,NS4b_78(SMMAF-SAAL)화NS5a_367(TVSSALAEL)여HLA-A2분자유고친화력(FI1);ELISPOT결과현시NS4b_78(SMMAFSAAL)화NS5a_367(TVSSALAEL)가유도고수평적분비IFN-γ적효응세포[분별위(60±6)SFC/10~4PBMC vs(4±1)SFC/10~4PBMC,P<0.001;(10±3)SFC/10~4PBMC vs(2±1)SFC/10~4PBMC,P<0.001];ICS결과증실저량조태자격HLA-A2양성PBMC후,재CD8~+T세포중산생료고백분비적CD8~+IFN-γ~+T[분별위(2.33±0.22)%vs(0.05±0.01)%,P<0.001;(0.36±0.06)%vs(0.03±0.01)%,P<0.001];병차,태특이성CTL가특이성살상부재상동태적T2세포.결론 NS4b_78(SMMAFSAAL)화NS5a_367(TVSSALAEL)수HIA-A2한제,병구유교호적면역원성.
Objective To explore the HLA-A2 restriction and immunogenicity of 5 previously identified HCV-speeific CTL epitopes. Methods Based on T2 cell, to explore the HLA-A2 restriction of previously identified HCV-specific CTL epitopes by MHC-peptide complex stabilization assay;To detect pep-tide-specific CTL in HLA-A2~+ PBMC stimulated by HLA-A2-restricted peptides by intracellular cytokine staining(ICS) and ELISPOT; To explore the cytotoxicity of peptide-specific CTL to same peptide-loaded T2 cells (target cells) by CTL cytotoxicity test. Results Among 5 previously identified CTL epitopes NS4b_78 (SMMAFSAAL) and NS5a_367 (TVSSALAEL) have high-affinity for HLA-A2 molecules(FI 1) ;ELISPOT results shown that NS4b_78(SMMAFSAAL) and NSSa_367(TVSSALAEL) induced high levels of IFN-γ-se-creting cells [(60±6) SFC/10~4 PBMC vs (4±1 ) SFC/10~4 PBMC, P < 0.01 ; (10 ± 3 ) SFC/10~4 PBMC vs (2±1 ) SFC/10~4 PBMC, P <0.01, respectively] ;ICS results indicated that there were high percentages of CD8~+ IFN-γ~+ T cells in total CD8~+T cells stimulated by these peptides [(2.33 ±0.22 ) % vs (0.05±0.01)%, P <0.001 ; (0.36±0.06)% vs (0.03±0.01)%, P <0.001, respectively]. Furthermore,peptide-specific CTL could effectively kill same peptide-loadcd T2 cells. Conclusion NS4b_78 (SMMAF-SAAL) and NSSa_367 (TVSSALAEL) were identified as HLA-A2-restricted CTL epitopes which could in-duce immune response in vitro.